These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The association of positive emotion and first smoking lapse: An ecological momentary assessment study. Vinci C; Li L; Wu C; Lam CY; Guo L; Correa-Fernández V; Spears CA; Hoover DS; Etcheverry PE; Wetter DW Health Psychol; 2017 Nov; 36(11):1038-1046. PubMed ID: 28726478 [TBL] [Abstract][Full Text] [Related]
4. Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. Piper ME; Cook JW; Schlam TR; Jorenby DE; Baker TB Addiction; 2011 Feb; 106(2):418-27. PubMed ID: 20973856 [TBL] [Abstract][Full Text] [Related]
5. Isolating the role of psychological dysfunction in smoking cessation: relations of personality and psychopathology to attaining cessation milestones. Leventhal AM; Japuntich SJ; Piper ME; Jorenby DE; Schlam TR; Baker TB Psychol Addict Behav; 2012 Dec; 26(4):838-49. PubMed ID: 22642858 [TBL] [Abstract][Full Text] [Related]
6. Lower self-efficacy and greater depressive symptoms predict greater failure to recover from a single lapse cigarette. Muench C; Malloy EJ; Juliano LM J Consult Clin Psychol; 2020 Oct; 88(10):965-970. PubMed ID: 33048572 [TBL] [Abstract][Full Text] [Related]
7. Early lapses in a cessation attempt: lapse contexts, cessation success, and predictors of early lapse. Deiches JF; Baker TB; Lanza S; Piper ME Nicotine Tob Res; 2013 Nov; 15(11):1883-91. PubMed ID: 23780705 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial. Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642 [TBL] [Abstract][Full Text] [Related]
9. Does cessation fatigue predict smoking-cessation milestones? A longitudinal study of current and former smokers. Heckman BW; Dahne J; Germeroth LJ; Mathew AR; Santa Ana EJ; Saladin ME; Carpenter MJ J Consult Clin Psychol; 2018 Nov; 86(11):903-914. PubMed ID: 30335423 [TBL] [Abstract][Full Text] [Related]
10. Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse. Schlam TR; Baker TB; Smith SS; Bolt DM; McCarthy DE; Cook JW; Hayes-Birchler T; Fiore MC; Piper ME Nicotine Tob Res; 2020 Oct; 22(11):2051-2058. PubMed ID: 32598468 [TBL] [Abstract][Full Text] [Related]
11. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations. Robles GI; Singh-Franco D; Ghin HL Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928 [TBL] [Abstract][Full Text] [Related]
12. The effect of five smoking cessation pharmacotherapies on smoking cessation milestones. Japuntich SJ; Piper ME; Leventhal AM; Bolt DM; Baker TB J Consult Clin Psychol; 2011 Feb; 79(1):34-42. PubMed ID: 21261432 [TBL] [Abstract][Full Text] [Related]
14. Relations among affect, abstinence motivation and confidence, and daily smoking lapse risk. Minami H; Yeh VM; Bold KW; Chapman GB; McCarthy DE Psychol Addict Behav; 2014 Jun; 28(2):376-88. PubMed ID: 24955665 [TBL] [Abstract][Full Text] [Related]
15. Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data. Cox LS; Faseru B; Mayo MS; Krebill R; Snow TS; Bronars CA; Nollen NL; Choi WS; Okuyemi KS; Salzman GA; Benowitz NL; Tyndale RF; Ahluwalia JS Trials; 2011 Jan; 12():22. PubMed ID: 21266057 [TBL] [Abstract][Full Text] [Related]
16. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. David SP; Strong DR; Leventhal AM; Lancaster MA; McGeary JE; Munafò MR; Bergen AW; Swan GE; Benowitz NL; Tyndale RF; Conti DV; Brown RA; Lerman C; Niaura R Addiction; 2013 Dec; 108(12):2202-11. PubMed ID: 23941313 [TBL] [Abstract][Full Text] [Related]
17. What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt. Piper ME; Vasilenko SA; Cook JW; Lanza ST Addiction; 2017 Feb; 112(2):330-339. PubMed ID: 27633341 [TBL] [Abstract][Full Text] [Related]
18. Dynamic effects of craving and negative affect on adolescent smoking relapse. Van Zundert RM; Ferguson SG; Shiffman S; Engels R Health Psychol; 2012 Mar; 31(2):226-34. PubMed ID: 21942749 [TBL] [Abstract][Full Text] [Related]
19. Independent and interactive effects of real-time risk factors on later temptations and lapses among smokers trying to quit. Bold KW; McCarthy DE; Minami H; Yeh VM; Chapman GB; Waters AJ Drug Alcohol Depend; 2016 Jan; 158():30-7. PubMed ID: 26585613 [TBL] [Abstract][Full Text] [Related]